[{"id":"d2316038-5eb0-4651-8f39-035fed4b78b0","acronym":"","url":"https://clinicaltrials.gov/study/NCT03994913","created_at":"2021-01-18T19:38:29.934Z","updated_at":"2024-07-02T16:35:50.573Z","phase":"Phase 1/2","brief_title":"Clinical Trial to Evaluate CD19 CAR T (CT032) in Patients With Relapsed and/or Refractory Non-Hodgkin's B Cell Lymphoma","source_id_and_acronym":"NCT03994913","lead_sponsor":"CARsgen Therapeutics Co., Ltd.","biomarkers":" IL6 • CXCL8 • IL2 • IL10","pipe":"","alterations":" ","tags":["IL6 • CXCL8 • IL2 • IL10"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • CT032"],"overall_status":"Completed","enrollment":" Enrollment 20","initiation":"Initiation: 08/14/2019","start_date":" 08/14/2019","primary_txt":" Primary completion: 01/20/2021","primary_completion_date":" 01/20/2021","study_txt":" Completion: 05/27/2021","study_completion_date":" 05/27/2021","last_update_posted":"2023-04-14"},{"id":"08310589-48de-424e-82b3-d1923ffca137","acronym":"","url":"https://clinicaltrials.gov/study/NCT03302403","created_at":"2021-01-18T16:18:51.239Z","updated_at":"2024-07-02T16:36:40.277Z","phase":"","brief_title":"Clinical Study of Redirected Autologous T Cells With a Chimeric Antigen Receptor in Patients With Malignant Tumors","source_id_and_acronym":"NCT03302403","lead_sponsor":"Kang YU","biomarkers":" CLDN18 • GPC3","pipe":" | ","alterations":" CD19 positive • GPC3 positive","tags":["CLDN18 • GPC3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD19 positive • GPC3 positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclophosphamide • fludarabine IV • satricabtagene autoleucel (CT041) • CT011 • CT0180 • CT032 • cyclophosphamide intravenous • zevorcabtagene autoleucel (CT053)"],"overall_status":"Active, not recruiting","enrollment":" Enrollment 18","initiation":"Initiation: 12/29/2017","start_date":" 12/29/2017","primary_txt":" Primary completion: 12/12/2020","primary_completion_date":" 12/12/2020","study_txt":" Completion: 12/12/2023","study_completion_date":" 12/12/2023","last_update_posted":"2020-10-08"}]